GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » FCF Margin %

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) FCF Margin % : -46.29% (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Beijing Bohui Innovation Biotechnology Group Co's Free Cash Flow for the three months ended in Sep. 2024 was ¥-73.7 Mil. Beijing Bohui Innovation Biotechnology Group Co's Revenue for the three months ended in Sep. 2024 was ¥159.2 Mil. Therefore, Beijing Bohui Innovation Biotechnology Group Co's FCF Margin % for the quarter that ended in Sep. 2024 was -46.29%.

As of today, Beijing Bohui Innovation Biotechnology Group Co's current FCF Yield % is -3.92%.

The historical rank and industry rank for Beijing Bohui Innovation Biotechnology Group Co's FCF Margin % or its related term are showing as below:

SZSE:300318' s FCF Margin % Range Over the Past 10 Years
Min: -51.23   Med: -18.91   Max: 20.03
Current: -19.35


During the past 13 years, the highest FCF Margin % of Beijing Bohui Innovation Biotechnology Group Co was 20.03%. The lowest was -51.23%. And the median was -18.91%.

SZSE:300318's FCF Margin % is ranked better than
66.76% of 1047 companies
in the Biotechnology industry
Industry Median: -135.76 vs SZSE:300318: -19.35


Beijing Bohui Innovation Biotechnology Group Co FCF Margin % Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co FCF Margin % Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.06 -15.73 -51.23 -15.17 -5.79

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.05 -2.94 -15.55 -22.18 -46.29

Competitive Comparison of Beijing Bohui Innovation Biotechnology Group Co's FCF Margin %

For the Biotechnology subindustry, Beijing Bohui Innovation Biotechnology Group Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Bohui Innovation Biotechnology Group Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Bohui Innovation Biotechnology Group Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Beijing Bohui Innovation Biotechnology Group Co's FCF Margin % falls into.



Beijing Bohui Innovation Biotechnology Group Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Beijing Bohui Innovation Biotechnology Group Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-60.528/1045.429
=-5.79 %

Beijing Bohui Innovation Biotechnology Group Co's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-73.688/159.179
=-46.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Bohui Innovation Biotechnology Group Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Bohui Innovation Biotechnology Group Co Business Description

Traded in Other Exchanges
N/A
Address
Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097
Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.
Executives
Niu Shu Hui Executives
Di Xiao Feng Director
Yang Qi Director
Lu Xin Qun Directors, executives
Zhang Lei Director
Wan Zhang Geng Executives
Song Rui Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines